These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity. Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412 [TBL] [Abstract][Full Text] [Related]
12. Detection of abacavir hypersensitivity by ELISpot method. Esser S; Jablonka R; Heinemann FM; Reuter S; Jaeger H; von Krosigk A; Schenk-Westkamp P; Schadendorf D; Horn PA; Lindemann M Inflamm Allergy Drug Targets; 2012 Jun; 11(3):227-34. PubMed ID: 22338581 [TBL] [Abstract][Full Text] [Related]
13. Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV. Quiros-Roldan E; Gardini G; Properzi M; Ferraresi A; Carella G; Marchi A; Malagoli A; Focà E; Castelli F Pharmacogenet Genomics; 2020 Oct; 30(8):167-174. PubMed ID: 32453265 [TBL] [Abstract][Full Text] [Related]
14. HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects. Small CB; Margolis DA; Shaefer MS; Ross LL BMC Infect Dis; 2017 Apr; 17(1):256. PubMed ID: 28399804 [TBL] [Abstract][Full Text] [Related]
16. The Role of Conformational Dynamics in Abacavir-Induced Hypersensitivity Syndrome. Fodor J; Riley BT; Kass I; Buckle AM; Borg NA Sci Rep; 2019 Jul; 9(1):10523. PubMed ID: 31324847 [TBL] [Abstract][Full Text] [Related]
17. HLA-B*57:01(+) abacavir-naive individuals have specific T cells but no patch test reactivity. Schnyder B; Adam J; Rauch A; Thurnheer MC; Pichler WJ J Allergy Clin Immunol; 2013 Sep; 132(3):756-758. PubMed ID: 23706613 [No Abstract] [Full Text] [Related]
18. Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA-B*57:01 binding and T-cell activation. Thomson PJ; Illing PT; Farrell J; Alhaidari M; Bell CC; Berry N; O'Neill PM; Purcell AW; Park KB; Naisbitt DJ Allergy; 2020 Mar; 75(3):636-647. PubMed ID: 31549414 [TBL] [Abstract][Full Text] [Related]
19. Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses. Adam J; Wuillemin N; Watkins S; Jamin H; Eriksson KK; Villiger P; Fontana S; Pichler WJ; Yerly D PLoS One; 2014; 9(4):e95339. PubMed ID: 24751900 [TBL] [Abstract][Full Text] [Related]
20. Successful translation of pharmacogenetics into the clinic: the abacavir example. Phillips E; Mallal S Mol Diagn Ther; 2009; 13(1):1-9. PubMed ID: 19351209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]